Original citation: J Clin Invest. 2009;119(6):1420–1428. doi:10.1172/JCI39104.
Citation for this corrigendum: J Clin Invest. 2010;120(5):1786. doi:10.1172/JCI39104C1.
In the section titled “Type 3 EMT: EMT associated with cancer progression and metastasis,” the phenotype of the cells purified from normal and malignant breast cancer tissue was given incorrectly. The correct sentence appears below.
Interestingly, CD44hiCD24lo cells purified from normal and malignant breast cancer tissue exhibit features of an EMT, and human cancer cells induced to undergo EMT exhibit stem cell–like properties and increased metastatic potential (84).
The authors regret the error.